September 20th 2024
The author discusses a program to prevent kidney decline and progression to dialysis by offering education, support services, and help navigating the health care system to those most at risk.
September 10th 2024
A National Perspective of the Opportunities, Challenges Facing Health Care Cost and Sustainability
November 11th 2021Michael E. Chernew, PhD, co-editor-in-chief of The American Journal of Managed Care®, discussed cost and sustainability issues specific to commercial insurance, Medicare, and Medicaid at the National Alliance 2021 Annual Forum held in a hybrid format in Washington, DC.
Read More
Managing Disparities in Chronic Kidney Disease Through Value-Based Arrangements
November 9th 2021On this episode of Managed Care Cast, we speak with Abi Sundaramoorthy, MD, MBA, executive vice president of clinical enterprise at Somatus, on fragmented care in chronic kidney disease, its disproportionate impact on minority communities, and the potential of value-based arrangements to address disparities and promote preventive, effective care.
Listen
Pfizer and BioNTech expect to seek emergency use authorization for their COVID-19 booster vaccine in all adults 18 years and older; the Biden administration urges appeals court to not block employer vaccine mandate; nearly 8 in 10 Americans believe or are unsure of false COVID-19 information.
Read More
The United States lifts travel restrictions for numerous countries, requiring proof of vaccination and in some cases negative COVID-19 tests; discrimination of any kind was associated with greater risk of mental health problems in young people; a controversial Alzheimer disease drug faces several uptake issues.
Read More
Dr Richard Wasserman on Changing Attitudes Toward Food Allergy OIT
November 8th 2021Richard Wasserman, MD, PhD, an allergist and immunologist with Allergy Partners of North Texas, an early adopter of food allergy oral immunotherapy (OIT), discusses how attitudes have changed around the practice.
Watch
In AD Biologics Debate, Therapy Choice Is Just Half of the Battle
November 5th 2021With new and expected future options for treating atopic dermatitis (AD), including an injectable biologic and an oral small molecule inhibitor, which is preferred and which makes the most sense for patients?
Read More
Dr Daniel Greer Discusses At-Risk Populations, Comorbidities of Chronic Insomnia
November 5th 2021Daniel Greer, PharmD, BCPP, clinical assistant professor, Rutgers Ernest Mario School of Pharmacy, speaks on at-risk populations of chronic insomnia, and the reciprocal relationship between the condition and other comorbidities.
Watch
Children With Atopic Dermatitis More Prone to Depression, Internalizing Behaviors
November 4th 2021Children with severe atopic dermatitis were shown to be at nearly 2-fold greater risk of both depression and internalizing behaviors, with mild disease also associated with internalizing behaviors in those as young as 4 years of age.
Read More
Ixekizumab Linked With Improved Outcomes vs Adalimumab in PsA With Concomitant Psoriasis
November 3rd 2021A greater proportion of biologic-naive patients with psoriatic arthritis treated with ixekizumab vs adalimumab achieved the combined endpoint of 100% resolution in the Psoriasis Area Severity Index and 50% or greater improvement in the American College of Rheumatology criteria at week 24 and 52.
Read More
California judge rules Allergan, Endo, Johnson & Johnson, and Teva not liable for state's opioid crisis; CDC panel to decide on approval of and recommendations for Pfizer/BioNTech's COVID-19 vaccine in children aged 5 to 11 years; screen time among teenagers more than doubled during the pandemic.
Read More
FDA announce it will need more time on its decision to approve Moderna’s COVID-19 vaccine in children aged 12 to 17 years; lingering questions as the Supreme Court proceeds with hearings on the legality of the Texas abortion law; global death toll from COVID-19 surpasses 5 million.
Read More
Biologic Treatment, Smoking May Increase Psoriasis Risk in Patients With IBD
October 29th 2021Patients with inflammatory bowel disease (IBD) treated with adalimumab had greater risk of developing psoriasis than those administered infliximab, with gender and smoking incidence also linked with greater IBD risk.
Read More
Leveraging Predictive Modeling, Data Analytics in Member Health Management
October 29th 2021Erika Glenn, Division Head of Sales, Care Management, CVS Health, addressed some of the latest innovations in predictive modeling and data analytics being leveraged by her organization in the management of patients with chronic conditions at the Asembia 2021 Specialty Pharmacy Summit in Las Vegas.
Read More
Aligning Value and Cost Considerations to Improve Access to, Outcomes of Gene Therapies
October 29th 2021A panel at Asembia 2021 Specialty Pharmacy Summit in Las Vegas addressed challenges in the treatment journey of patients with rare diseases, efforts to improve access to gene therapies, and cost and value considerations for stakeholders.
Read More
Unraveling the Growing Influence of Consolidation, 340B, and Industry in Specialty Pharmacy
October 27th 2021Panelists of the opening session at Asembia 2021 Specialty Pharmacy Summit in Las Vegas address emerging shifts in specialty pharmacy, its impact on the health care system, and future implications post pandemic.
Read More
Diagnostic Testing in Thyroid Cancer: An AJMC® Profiles in Care
October 27th 2021Michelle Afkhami, MD, from City of Hope, discusses best practices for oncology organizations to leverage molecular/genomic testing, the importance of identifying RET-positive patients early so they can receive targeted treatment, and more.
Listen
Addressing Senior Health Needs Amid the COVID-19 Pandemic
October 26th 2021On this episode of Managed Care Cast, we discuss senior health needs amid the pandemic and how Centerwell Senior Primary Care's holistic, team-based approach and value-based care delivery contributed to upticks in senior patient visits despite fears of COVID-19.
Listen